GOSH joins partnership to boost early diagnosis and deliver better treatments

12 Feb 2026, 11:42 a.m.

A young girl holds up two of her fingers (the 'peace' sign') with a man and woman leaning in to her, in a selfie pose with a city backdrop. They look happy.

Great Ormond Street Hospital (GOSH) is partnering with LifeArc, a charity dedicated to rare disease research, to set up KidsRare - a new initiative to help deliver more tests and treatments for children living with a rare disease.

The project will drive the secure use of health data to develop insights and breakthroughs that could turbocharge rare disease research and help the thousands of children diagnosed with rare diseases every year in the UK.

Rare disease health data is often fragmented and disconnected due to small numbers living with the conditions, which can hold back research. There is an urgent need for change with more than 3 million people in the UK living with a rare disease, and approximately 70 per cent of those diseases affecting children. Currently 95 per cent of rare diseases have no approved treatments.

Harnessing the power of data through partnership

The programme will, for the first-time, allow researchers to harness the potential of high-quality health data sets that exist across different hospitals across the UK for children and young people in the UK living with a rare disease.

Connecting data in this way makes it possible to generate insights and breakthroughs based on what health data is saying about a patient, which can support our ability to diagnose and deliver the right treatments and care, at the right time.

Professor Neil Sebire, Chief Research Information Officer at GOSH, said, “Harnessing paediatric specialist data is pivotal for rare disease research. Collaboration is key to securely transform data that is locked in multiple, unconnected locations into insights that accelerates innovation and improve outcomes for children with rare disease.”

This first-ever health data resource could make the UK a go-to for innovation and research in rare diseases which affect more than 300 million people around the world.

Making a difference for Lucia

A young girl holds up an ice cream and gives a thumbs up to the camera. She is smiling widely.

The impact of connecting data in this way is clear for Francesca whose daughter, Lucia, was diagnosed with a rare condition, Hao Fountain Syndrome. This can lead to developmental delay, speech issues and problems with vision.

“From birth, we knew that something wasn’t quite right. Lucia wasn’t weight bearing at 9 months, she had issues with her vision which meant she was very short-sighted and she wasn’t able to speak until she was 3 years old. We spoke to doctors and they said she had global developmental delay but used this term because they didn’t know the cause. This carried on for many years, and it made it hard to get the support we needed.”

It wasn’t until they were referred by a specialist to take part in the 100,000 Genomes Project run by Genomics England that they had a breakthrough.

“We had a call one day out of the blue that said that they had a diagnosis for Lucia – Hao Fountain Syndrome. They had been able to make the diagnosis because they had access to more data. Knowing the name of the condition allowed us to speak to other families about their experience, to build a community of support and prepare for the future.”

“Having this data made this possible, and we want this for more families living with a rare disease. Children need the best start in life and getting a diagnosis sooner means having more knowledge, and maybe, in the future, it could help lead to new treatments. The KidsRare initiative could really change so many lives.”

This initiative builds on work already undertaken by the GOSH and the Children’s Hospital Alliance through the GOSH DRIVE (Data Research, Innovation and Virtual Environments) unit. It follows the highest standards of data security and only approved researchers can access to the anonymised health data it contains.

How linked health and education data is changing what we know about children with neurodisability

Children with neurodisability often have complex health and educational needs, but population level data on long term outcomes remains limited. New research from GOS-ICH addresses this gap using one of the largest national birth cohorts to date.

Study sheds light on sight-threatening arthritis in children

A team from UCL GOSH and Moorfields Eye Hospital, have discovered B-cells alongside T-cells, play a major role in the development of arthritis‑associated eye disease, JIA‑uveitis.

Orthopaedic Review: End of patient recall report published

Today we have published the summary of our findings.

Lab-grown mini-stomachs could boost understanding of rare diseases

Researchers at Great Ormond Street Hospital (GOSH) and University College London (UCL) have developed the first-ever lab-grown mini-stomach that contains the key components of the full-sized human organ.